Menu
Search

News

Swiss Deep Tech News & Analysis

Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.

Curated Newsfeed

See all news

DTN Highlights

See DTN Highlights

  • Aramco Ventures invests in GraphEnergyTech’s seed funding round

    GraphEnergyTech, a UK-Swiss deeptech company developing metal-free electrodes, has secured the first close of its seed funding round, with Aramco Ventures among the committed investors.…

    startupticker.ch

    • GraphEnergyTech closed seed funding with Aramco Ventures, targeting £3M total to scale metal-free electrode technology.
    • The company uses carbon and graphene inks to make electrodes without gold or silver, reducing metal market exposure.
    • GET is expanding from solar panels into fuel cells, heating, and printed electronics with major grant backing.
    startupticker.ch: Aramco Ventures invests in GraphEnergyTech’s seed funding round

  • Candi Solar secures USD50 million to finance projects in India

    The facility will finance rooftop, ground-mounted, and open-access solar installations paired with BESS across key business hubs in India. This will enable the avoidance of…

    startupticker.ch

    • Candi Solar secured $50M from Pentagreen Capital to finance 400MWp of solar and battery storage for India's SME segment.
    • The partnership will deploy rooftop, ground-mounted, and open-access solar to avoid 397,000 tonnes of CO2 emissions annually.
    • Candi plans to reach 1GW operational solar capacity within 24 months through this financing and planned equity rounds.
    startupticker.ch: Candi Solar secures USD50 million to finance projects in India

  • Swiss Fintechs to showcase innovation in Singapore

    The next edition of the Singapore Fintech Festival which takes place from 18-20 November, will host the Swiss Pavilion for the 10th consecutive year. Ten…

    startupticker.ch

    • Swiss fintech startups showcase AI, cybersecurity, and digital assets at Singapore FinTech Festival, Nov 18-20.
    • SFF attracts 70,000+ participants from 142 countries, 600+ exhibitors, and facilitates 20,000+ meetings across 300+ sessions.
    • Swiss startups offer blockchain recovery, biometrics, AI governance, RegTech, and cybersecurity solutions for Asia's financial sector.
    startupticker.ch: Swiss Fintechs to showcase innovation in Singapore

  • Ascend clarifies stock market plans

    EvoNext Holdings SA and Ascend Sport Technology have signed a merger agreement. Through the merger Ascend will become a publicly listed entity. The transaction will…

    startupticker.ch

    • EvoNext Holdings SA and Ascend Sport Technology will merge to create a publicly listed Swiss sports tech company on SIX.
    • Ascend achieved CHF 44M revenue and CHF 25M EBITDA (57% margin) in FY 25/26, targeting 100% growth over four years.
    • The merger includes a CHF 220M share placement at CHF 2.50 per share, with shareholder vote on December 3, 2026.
    startupticker.ch: Ascend clarifies stock market plans

  • Netflix Ads expands data clean-room capabilities with Decentriq

    Decentriq is expanding its footprint in the advertising industry as Netflix Ads extends its use of data clean rooms across its 12 ad-supported markets. The…

    startupticker.ch

    • Netflix Ads expands data clean room usage across 12 ad-supported markets, signaling growing adoption of privacy-preserving collaboration technology.
    • Decentriq is expanding into healthcare and financial services beyond ads, positioning AI as its next major growth opportunity.
    startupticker.ch: Netflix Ads expands data clean-room capabilities with Decentriq

  • First ANYmals for explosive environments set for shipment

    ANYmal X is the world’s first four-legged inspection robot designed to operate in hazardous environments of oil, gas, and chemical sectors while meeting safety standards.…

    startupticker.ch

    • ANYmal X is a four-legged inspection robot for hazardous oil, gas, and chemical environments with thermal, visual, acoustic, and gas sensors.
    • ANYmal X meets ATEX and IECEx safety certifications with nitrogen-filled chambers and flameproof casings for explosion-prone facilities.
    • ANYbotics' Shift platform integrates inspection data with plant maintenance software like SAP and Yokogawa for asset health tracking.
    startupticker.ch: First ANYmals for explosive environments set for shipment

  • Atlas Bio steps out of stealth with $12.5m funding

    The Swiss tech-bio, which has been founded by ex-Google technologists, pharma and AI experts, simulates patient-level efficacy and safety signals before Phase II and aims…

    startupticker.ch

    • Atlas Bio raised $12.5M to simulate drug trials using AI trained on 2M RNA readouts, targeting the 70% failure rate of Phase II trials.
    • The platform identifies off-label treatment opportunities by running simulations across diseases, surfacing signals traditional Phase II designs miss.
    • A Basel biotech client eliminated animal testing by proceeding directly to human trials using Atlas Bio's simulation.
    startupticker.ch: Atlas Bio steps out of stealth with $12.5m funding

  • Windward Bio files for IPO at Nasdaq

    Basel-based Windward Bio, a clinical-stage biotechnology company focussing on immunological diseases has applied to list its common shares on the Nasdaq Global Market. Since launching…

    startupticker.ch

    • Basel-based Windward Bio filed for Nasdaq listing after raising $365M for ultra-long-acting antibody medicines.
    • WIN378 demonstrated a 75-day half-life enabling twice-yearly dosing for asthma and COPD patients.
    • WIN027 bispecific antibody targeting TSLP and IL-13 showed a 62-day half-life with low immunogenicity.
    startupticker.ch: Windward Bio files for IPO at Nasdaq

  • Up to $ 70M Term Loan Facility to boost Distalmotion US ASC Expansion

    Distalmotion, the global MedTech company focused on expanding access to robotic surgery in outpatient settings, recently announced that it has entered into a senior secured…

    startupticker.ch

    • DEXTER is cleared for four high-volume soft tissue outpatient procedures: cholecystectomy, inguinal hernia repair, ventral hernia repair, and hysterectomy.
    startupticker.ch: Up to $ 70M Term Loan Facility to boost Distalmotion US ASC Expansion

  • Physical AI company Enact Intelligence emerges from stealth with $30m pre-seed funding

    Enact Intelligence is building robots which can not only see their surroundings but also have a sense of force and touch. The Zurich-based start-up will…

    startupticker.ch

    • Enact Intelligence raised $30M to build robots with integrated force and touch sensing, overcoming vision-only limitations.
    • The Zurich startup plans to expand fivefold by 2027 and deploy robots across manufacturing, infrastructure, retail, and food.
    • Enact combines Silicon Valley AI expertise with Swiss engineering to create physics-aware robots that learn from real-world use.
    startupticker.ch: Physical AI company Enact Intelligence emerges from stealth with $30m pre-seed funding

  • Apple acquires Swiss Samplab

    According to an EU acquisition register, Apple has acquired assets from the Swiss company Samplab GmbH. The solutions offered by the start-up, which was founded…

    startupticker.ch

    • Apple acquired Samplab GmbH's audio assets in June 2026, gaining AI tech that converts polyphonic audio into editable MIDI notes.
    • As an EU Digital Markets Act gatekeeper, Apple notified authorities of the acquisition, with details disclosed in an EU register.
    • Samplab shut down in September 2026 with its website redirecting to Apple's, indicating Apple bought software rights only.
    startupticker.ch: Apple acquires Swiss Samplab

  • Nouscom raises $135 Million to advance its cancer immunotherapy

    Basel-based Nouscom closed an oversubscribed $135 million Series D financing. Proceeds will fund advancement of Nouscom’s lead asset NOUS-209, an investigational, off-the-shelf neoantigen-based cancer immunotherapy…

    startupticker.ch

    • Nouscom raised $135M Series D for NOUS-209, a neoantigen immunotherapy to prevent cancer in Lynch Syndrome carriers with up to 80% lifetime risk.
    • Phase 1b/2 trial: all Lynch Syndrome carriers on NOUS-209 remained free of advanced adenomas and colorectal cancer through years 1-2.
    • FDA granted Fast Track designation for NOUS-209's registration trial, positioning it as a potential breakthrough cancer prevention vaccine.
    startupticker.ch: Nouscom raises $135 Million to advance its cancer immunotherapy